Organ-on-Chip Market by Offering (Services, Products), by Type (Liver-on-Chip, Lung-on-Chip, Kidney-on-Chip, Heart-on-Chip, Intestine-on-Chip, Brain-on-Chip), by Application (Toxicology Research, Physiological Model Development, Drug Discovery), by End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes), by Geography (U.S., Canada, Germany, U.K., France, China, Japan) – Global Market Size, Share, Development, Growth and Demand Forecast, 2016–2025

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Offering

1.3.2 Market Segmentation by Type

1.3.3 Market Segmentation by Application

1.3.4 Market Segmentation by End User

1.3.5 Market Segmentation by Geography

1.3.6 Analysis Period

1.3.7 Market Data Reporting Unit

1.3.7.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

3.1 Voice of Industry Experts/KOLs

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Offering

4.1.1.1 Services

4.1.1.2 Products

4.1.2 By Type

4.1.2.1 Liver-on-chip

4.1.2.2 Lung-on-chip

4.1.2.3 Kidney-on-chip

4.1.2.4 Heart-on-chip

4.1.2.5 Intestine-on-chip

4.1.2.6 Brain-on-chip

4.1.2.7 Others

4.1.3 By Application

4.1.3.1 Toxicology research

4.1.3.2 Physiological model development

4.1.3.3 Drug discovery

4.1.4 By End User

4.1.4.1 Pharmaceutical and biotechnology companies

4.1.4.2 Academic and research institutes

4.1.4.3 Others

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Increasing product launches

4.2.1.2 Rising collaboration among major players

4.2.2 Drivers

4.2.2.1 Rising need for effective drug discovery and development

4.2.2.2 Increasing demand for alternatives for animal models in research

4.2.2.3 Increasing drug repurposing approaches

4.2.2.4 Government grants and funds for research

4.2.2.5 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 Use of polydimethylsiloxane in organ-on-chip microdevices

4.2.3.2 Transition from the laboratory to industrial production

4.2.3.3 Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.2.4.1 Demand for personalized medication

4.2.4.2 Vast application of organ-on-chip beyond pharmaceutical industry

4.3 Porter’s Five Forces Analysis

4.3.1 Bargaining Power of Buyers

4.3.2 Bargaining Power of Suppliers

4.3.3 Intensity of Rivalry

4.3.4 Threat of New Entrants

4.3.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast

5.1 By Offering

5.2 By Type

5.3 By Application

5.4 By End User

5.5 By Region

Chapter 6. North America Market Size and Forecast

6.1 By Offering

6.2 By Type

6.3 By Application

6.4 By End User

6.5 By Country

Chapter 7. Europe Market Size and Forecast

7.1 By Offering

7.2 By Type

7.3 By Application

7.4 By End User

7.5 By Country

Chapter 8. APAC Market Size and Forecast

8.1 By Offering

8.2 By Type

8.3 By Application

8.4 By End User

8.5 By Country

Chapter 9. RoW Market Size and Forecast

9.1 By Offering

9.2 By Type

9.3 By Application

9.4 By End User

Chapter 10. Competitive Landscape

10.1 Competitive Benchmarking of Key Players

10.2 Global Strategic Developments of Key Players

10.2.1 Product Launches

10.2.2 Partnerships

10.2.3 Other Developments

Chapter 11. Company Profiles

11.1 Emulate, Inc.

11.1.1 Business Overview

11.1.2 Product and Service Offerings

11.2 InSphero AG

11.2.1 Business Overview

11.2.2 Product and Service Offerings

11.3 Hµrel Corporation

11.3.1 Business Overview

11.3.2 Product and Service Offerings

11.4 Mimetas B.V.

11.4.1 Business Overview

11.4.2 Product and Service Offerings

11.5 TissUse GmbH

11.5.1 Business Overview

11.5.2 Product and Service Offerings

11.6 Kirkstall Ltd

11.6.1 Business Overview

11.6.2 Product and Service Offerings

11.7 CN Bio Innovations Ltd

11.7.1 Business Overview

11.7.2 Product and Service Offerings

11.8 Ascendance Biotechnology, Inc.

11.8.1 Business Overview

11.8.2 Product and Service Offerings

11.9 Nortis, Inc.

11.9.1 Business Overview

11.9.2 Product and Service Offerings

11.1 Organovo Holdings, Inc.

11.10.1 Business Overview

11.10.2 Product and Service Offerings

11.10.3 Key Financial Summary

11.10.4 Strategic Growth Plans

11.11 TARA Biosystems, Inc.

11.11.1 Business Overview

11.11.2 Product and Service Offerings

11.12 AxoSim Technologies, LLC

11.12.1 Business Overview

11.12.2 Product and Service Offerings

Chapter 12. Appendix

12.1 Abbreviations

12.2 Sources and References

12.3 Related Reports

 

LIST OF TABLES

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 GLOBAL ORGAN-ON-CHIP MARKET, BY OFFERING, $’000 (2016–2025)

TABLE 5 GLOBAL ORGAN-ON-CHIP MARKET, BY TYPE, $’000 (2016–2025)

TABLE 6 GLOBAL ORGAN-ON-CHIP MARKET, BY APPLICATION, $’000 (2016–2025)

TABLE 7 GLOBAL ORGAN-ON-CHIP MARKET, BY END USER, $’000 (2016–2025)

TABLE 8 GLOBAL ORGAN-ON-CHIP MARKET, BY REGION, $’000 (2016–2025)

TABLE 9 NORTH AMERICA ORGAN-ON-CHIP MARKET, BY OFFERING, $’000 (2016–2025)

TABLE 10 NORTH AMERICA ORGAN-ON-CHIP MARKET, BY TYPE, $’000 (2016–2025)

TABLE 11 NORTH AMERICA ORGAN-ON-CHIP MARKET, BY APPLICATION, $’000 (2016–2025)

TABLE 12 NORTH AMERICA ORGAN-ON-CHIP MARKET, BY END USER, $’000 (2016–2025)

TABLE 13 NORTH AMERICA ORGAN-ON-CHIP MARKET, BY COUNTRY, $’000 (2016–2025)

TABLE 14 EUROPE ORGAN-ON-CHIP MARKET, BY OFFERING, $’000 (2016–2025)

TABLE 15 EUROPE ORGAN-ON-CHIP MARKET, BY TYPE, $’000 (2016–2025)

TABLE 16 EUROPE ORGAN-ON-CHIP MARKET, BY APPLICATION, $’000 (2016–2025)

TABLE 17 EUROPE ORGAN-ON-CHIP MARKET, BY END USER, $’000 (2016–2025)

TABLE 18 EUROPE ORGAN-ON-CHIP MARKET, BY COUNTRY, $’000 (2016–2025)

TABLE 19 APAC ORGAN-ON-CHIP MARKET, BY OFFERING, $’000 (2016–2025)

TABLE 20 APAC ORGAN-ON-CHIP MARKET, BY TYPE, $’000 (2016–2025)

TABLE 21 APAC ORGAN-ON-CHIP MARKET, BY APPLICATION, $’000 (2016–2025)

TABLE 22 APAC ORGAN-ON-CHIP MARKET, BY END USER, $’000 (2016–2025)

TABLE 23 APAC ORGAN-ON-CHIP MARKET, BY COUNTRY, $’000 (2016–2025)

TABLE 24 ROW ORGAN-ON-CHIP MARKET, BY OFFERING, $’000 (2016–2025)

TABLE 25 ROW ORGAN-ON-CHIP MARKET, BY TYPE, $’000 (2016–2025)

TABLE 26 ROW ORGAN-ON-CHIP MARKET, BY APPLICATION, $’000 (2016–2025)

TABLE 27 ROW ORGAN-ON-CHIP MARKET, BY END USER, $’000 (2016–2025)

TABLE 28 EMULATE, INC. – AT A GLANCE

TABLE 29 INSPHERO AG – AT A GLANCE

TABLE 30 HµREL CORPORATION – AT A GLANCE

TABLE 31 MIMETAS B.V. – AT A GLANCE

TABLE 32 TISSUSE GMBH – AT A GLANCE

TABLE 33 KIRKSTALL LTD – AT A GLANCE

TABLE 34 CN BIO INNOVATIONS LTD – AT A GLANCE

TABLE 35 ASCENDANCE BIOTECHNOLOGY, INC. – AT A GLANCE

TABLE 36 NORTIS, INC. – AT A GLANCE

TABLE 37 ORGANOVO HOLDINGS, INC. – AT A GLANCE

TABLE 38 ORGANOVO HOLDINGS, INC. – KEY FINANCIAL SUMMARY

TABLE 39 TARA BIOSYSTEMS, INC. – AT A GLANCE

TABLE 40 AXOSIM TECHNOLOGIES, LLC – AT A GLANCE

 

LIST OF FIGURES

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 GLOBAL ORGAN-ON-CHIP MARKET SUMMARY

FIG 9 OPINION OF INDUSTRY EXPERTS/KOLS

FIG 10 PORTER’S FIVE FORCES ANALYSIS

FIG 11 SNAPSHOT OF ORGAN-ON-CHIP MARKET (2023)

FIG 12 GLOBAL ORGAN-ON-CHIP MARKET, BY OFFERING, $’000 (2016–2025)

FIG 13 GLOBAL ORGAN-ON-CHIP MARKET, BY TYPE, $’000 (2016–2025)

FIG 14 GLOBAL ORGAN-ON-CHIP MARKET, BY APPLICATION, $’000 (2016–2025)

FIG 15 GLOBAL ORGAN-ON-CHIP MARKET, BY END USER, $’000 (2016–2025)

FIG 16 WORLDWIDE MAJOR MARKETS FOR ORGAN-ON-CHIP

FIG 17 NORTH AMERICA ORGAN-ON-CHIP MARKET SNAPSHOT

FIG 18 NORTH AMERICA ORGAN-ON-CHIP MARKET, BY OFFERING, $’000 (2016–2025)

FIG 19 NORTH AMERICA ORGAN-ON-CHIP MARKET, BY TYPE, $’000 (2016–2025)

FIG 20 NORTH AMERICA ORGAN-ON-CHIP MARKET, BY APPLICATION, $’000 (2016–2025)

FIG 21 NORTH AMERICA ORGAN-ON-CHIP MARKET, BY END USER, $’000 (2016–2025)

FIG 22 NORTH AMERICA ORGAN-ON-CHIP MARKET, BY COUNTRY, $’000 (2016–2025)

FIG 23 EUROPE ORGAN-ON-CHIP MARKET SNAPSHOT

FIG 24 EUROPE ORGAN-ON-CHIP MARKET, BY OFFERING, $’000 (2016–2025)

FIG 25 EUROPE ORGAN-ON-CHIP MARKET, BY TYPE, $’000 (2016–2025)

FIG 26 EUROPE ORGAN-ON-CHIP MARKET, BY APPLICATION, $’000 (2016–2025)

FIG 27 EUROPE ORGAN-ON-CHIP MARKET, BY END USER, $’000 (2016–2025)

FIG 28 EUROPE ORGAN-ON-CHIP MARKET, BY COUNTRY, $’000 (2016–2025)

FIG 29 APAC ORGAN-ON-CHIP MARKET SNAPSHOT

FIG 30 APAC HEALTHCARE EXPENDITURE (AS A % OF GDP)

FIG 31 APAC ORGAN-ON-CHIP MARKET, BY OFFERING, $’000 (2016–2025)

FIG 32 APAC ORGAN-ON-CHIP MARKET, BY TYPE, $’000 (2016–2025)

FIG 33 APAC ORGAN-ON-CHIP MARKET, BY APPLICATION, $’000 (2016–2025)

FIG 34 APAC ORGAN-ON-CHIP MARKET, BY END USER, $’000 (2016–2025)

FIG 35 APAC ORGAN-ON-CHIP MARKET, BY COUNTRY, $’000 (2016–2025)

FIG 36 ROW ORGAN-ON-CHIP MARKET SNAPSHOT

FIG 37 ROW ORGAN-ON-CHIP MARKET, BY OFFERING, $’000 (2016–2025)

FIG 38 ROW ORGAN-ON-CHIP MARKET, BY TYPE, $’000 (2016–2025)

FIG 39 ROW ORGAN-ON-CHIP MARKET, BY APPLICATION, $’000 (2016–2025)

FIG 40 ROW ORGAN-ON-CHIP MARKET, BY END USER, $’000 (2016–2025)

FIG 41 COMPETITIVE BENCHMARKING OF KEY PLAYERS